SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-014468
Filing Date
2022-08-04
Accepted
2022-08-04 07:13:26
Documents
14
Period of Report
2022-08-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dna-20220802.htm   iXBRL 8-K 75191
2 EX-99.1 dna-ex99_1.htm EX-99.1 15457
  Complete submission text file 0000950170-22-014468.txt   264810

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20220802_pre.xml EX-101.PRE 15313
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20220802_lab.xml EX-101.LAB 24085
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20220802_def.xml EX-101.DEF 15076
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20220802.xsd EX-101.SCH 3381
8 EXTRACTED XBRL INSTANCE DOCUMENT dna-20220802_htm.xml XML 6552
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 221134649
SIC: 2836 Biological Products, (No Diagnostic Substances)